
Armata Pharmaceuticals, Inc. (ARMP) Stock Ticker
ARMP right now
Market factors today
Unlock the full ARMP picture
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
ARMP stock facts
| Ticker symbol | ARMP |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $137.3M |
| CEO | Deborah L. Birx |
| Employees | 61 |
| Headquarters | Los Angeles, CA, US |
| IPO date | 1994-05-20 |
| Website | www.armatapharma.com |
What you can see for ARMP on Tickr
Live ARMP price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ARMP report.
Rankings
FAQ
What is the ticker symbol for Armata Pharmaceuticals, Inc.?
The ticker symbol for Armata Pharmaceuticals, Inc. is ARMP, listed on the New York Stock Exchange Arca.
What is ARMP?
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product…